Related Experiment Video
Updated: Oct 17, 2025
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis
Jonathan Broomfield1, Micki Hill2, Michela Guglieri2
1From the Department of Health Sciences (J.B., M.H.), University of Leicester; Institute of Human Genetics (M.G.), Newcastle University, UK; Department of Medical Epidemiology and Biostatistics (M.C.), Karolinska Institute, Stockholm, Sweden; and Centre for Health Economics (K.A.), University of York, UK. jb781@le.ac.uk.
Life expectancy for Duchenne muscular dystrophy (DMD) patients has significantly improved, reaching a median of 28.1 years for those born after 1990. This study reconstructs individual patient data from literature to estimate DMD mortality rates.
Area of Science:
- Medical Research
- Genetics and Hereditary Diseases
- Neurology
Background:
- Duchenne muscular dystrophy (DMD) is a rare, progressive genetic disorder impacting life expectancy.
- Limited patient numbers and research literature pose challenges in fully understanding DMD's natural history.
- Accurate life expectancy and mortality estimates are crucial for DMD patient care and research.
Purpose of the Study:
- To estimate life expectancy and mortality rates in Duchenne muscular dystrophy patients.
- To analyze trends in DMD survival over time.
- To explore the utility of reconstructing individual patient data from literature for rare disease research.
Main Methods:
- Systematic literature review of DMD mortality studies up to July 2020.
- Digitization and reconstruction of individual patient data (IPD) from Kaplan-Meier survival curves.
- Analysis of pooled IPD using Kaplan-Meier and parametric survival models, stratified by birth cohort.
Main Results:
- Median life expectancy for DMD patients was 22.0 years.
- Patients born after 1990 showed a significantly increased median life expectancy of 28.1 years.
- Data from 14 publications on 2,283 patients (1,049 deaths) were analyzed.
Conclusions:
- Life expectancy for Duchenne muscular dystrophy patients has markedly improved in recent decades.
- Reconstructing IPD from published literature is a viable method for estimating life expectancy in rare diseases like DMD.
- This study provides a comprehensive overview of DMD mortality, highlighting recent survival improvements.
